DESIGN OF PRONIOSOMAL GEL CONTAINING EUGENOL AS AN ANTIFUNGAL AGENT FOR THE TREATMENT OF ORAL CANDIDIASIS
Authors:
- T. S VishnuTVT. S Vishnu
- A. DubeyADA. Dubey
- G.S RaviGRG.S Ravi
- S. HebbarSHS. Hebbar
- 28 September 2018
- journal article
- Published by Indian Drug Manufacturers' Association (IDMA) in INDIAN DRUGS
- Vol. 55 (09) , 55-57
Abstract
The objective of this study was to design and investigate the antifungal activity of proniosomal gel of eugenol for the treatment of oral candidiasis. The proniosomal gel was prepared by coacervation phase separation method using different surfactants like spans 20, 60, 80, soya lecithin and cholesterol. The proniosomal gel formulations were evaluated for visual inspection, pH detection, viscosity, spreadability, in vitro drug release and kinetics study, and in vivo studies. The compatibility study indicated that the drug and the excipients were compatible with each other. The results showed that pH, viscosity and spreadability were all acceptable for topical preparation. In vitro drug release study and drug release kinetics were conducted to check the release study and drug release patterns of the formulation. Amongst the formulations, an optimized formulation was selected to conduct an in vivo study. Candida albicans was used to induce oral candidiasis for the evaluation of therapeutic efficacy of proniosomal gel in immunosuppressed rats. Activity was analysed by microbiological and histopathological techniques and was compared with the marketed product. It is evident from the study that the proniosomal gel shows sustained release trend with strong antifungal activity.Keywords
This publication has 10 references indexed in Scilit:
- Oropharyngeal Candidiasis in HIV Infection: Analysis of Impaired Mucosal Immune Response to Candida albicans in Mice Expressing the HIV-1 TransgenePathogens, 2015
- Oro-dental mucoadhesive proniosomal gel formulation loaded with lornoxicam for management of dental painJournal of Liposome Research, 2014
- A review on proniosomal drug delivery system for targeted drug actionJournal of Basic and Clinical Pharmacy, 2013
- Evaluation of carvacrol and eugenol as prophylaxis and treatment of vaginal candidiasis in an immunosuppressed rat modelJournal of Antimicrobial Chemotherapy, 2004
- Antifungal treatment with carvacrol and eugenol of oral candidiasis in immunosuppressed ratsThe Brazilian Journal of Infectious Diseases, 2004
- Antifungal Activities of Two New Azasordarins, GW471552 and GW471558, in Experimental Models of Oral and Vulvovaginal Candidiasis in Immunosuppressed RatsAntimicrobial Agents and Chemotherapy, 2001
- Proniosomes: A Novel Drug Carrier PreparationInternational Journal of Pharmaceutics, 1999
- In vitro antifungal activity of eugenol and vanillin against Candida albicans and Cryptococcus neoformansCanadian Journal of Microbiology, 1982
- Preparation and Evaluation of Proniosomal Gel of Neem Seed OilInternational Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN), 1970
- Mechanism of sustained‐action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matricesJournal of Pharmaceutical Sciences, 1963